China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

By Russell Flannery, Forbes Staff in /worlds-billionaires, Forbes, healthcare, Investing, Markets, russellflanneryblog
June 6, 2022

Purchase to help expansion in Southeast Asia

Read the full post on Forbes - Healthcare

Russell Flannery, Forbes Staff